secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001854270-25-000077
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Bio appoints Bryan Baum to Board of Directors
---------------------------------------------------

- Bryan Baum, co-founder and managing partner of K5 Global, appointed to board effective July 18, 2025.
- Baum received initial option award for 43,900 shares vesting monthly over three years; annual cash retainer $35,000.
- Board size increased from seven to eight members; Baum fills new seat as Class II director until 2027 annual meeting.
- Baum's portfolio includes SpaceX, xAI, Anduril, OpenAI; previously sold companies Blue Vision Labs, Parrot, Operam.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427025000077/0001854270-25-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427025000077/snti-20250718.htm
  HTML page:      https://secwatch.observer/filing/0001854270-25-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer